You have 9 free searches left this month | for more free features.

d-serine

Showing 1 - 25 of 6,554

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial in Basel (D-serine, Placebo)

Recruiting
  • Major Depressive Disorder
  • D-serine
  • Placebo
  • Basel, Baselstadt, Switzerland
    University of Basel, Department of Psychiatry (UPK)
Oct 31, 2022

Schizophrenia, Schizo Affective Disorder Trial in New York (D-serine, Placebo)

Not yet recruiting
  • Schizophrenia
  • Schizo Affective Disorder
  • D-serine
  • Placebo
  • New York, New York
    New York State Psychiatric
Jul 25, 2022

Psychotic Disorder Trial in Basel (D-serine, Placebo)

Recruiting
  • Psychotic Disorder
  • D-serine
  • Placebo
  • Basel, Basel-Stadt, Switzerland
    UPK Basel
Jan 21, 2022

Schizophrenia Trial in New Haven, Glen Oaks, Orangeburg (D-serine)

Completed
  • Schizophrenia
  • D-serine
  • New Haven, Connecticut
  • +2 more
Sep 11, 2020

Schizophrenia Trial in Orangeburg (D-serine)

Completed
  • Schizophrenia
  • D-serine
  • Orangeburg, New York
    Nathan Kline Institute
Sep 14, 2020

Postoperative Cognitive Dysfunction Trial (Blood sampling for assessment of the level of D-Amino Acid Oxidase, D-serine and

Unknown status
  • Postoperative Cognitive Dysfunction
  • Blood sampling for assessment of the level of D-Amino Acid Oxidase, D-serine and Serine in blood
  • +2 more
  • (no location specified)
Dec 21, 2020

Rosacea Trial in San Diego (Ivermectin)

Completed
  • Rosacea
  • San Diego, California
    UCSD Division of Dermatology
Oct 1, 2021

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Completed
  • Metastatic Melanoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Metastatic Uveal Melanoma
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

Active, not recruiting
  • Metastatic Melanoma
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston

Active, not recruiting
  • HLA-A*0201 Positive Cells Present
  • +3 more
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Aldesleukin
  • +12 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 9, 2023

Hereditary Sensory Neuropathy Type I Trial in London (L-serine, Placebo)

Recruiting
  • Hereditary Sensory Neuropathy Type I
  • London, United Kingdom
    University College London
Oct 31, 2023

Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

Recruiting
  • Bone Sarcoma
  • +15 more
  • Aldesleukin
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Healthy Volunteers Trial in Adelaide (CTP-692, D-Serine)

Completed
  • Healthy Volunteers
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Mar 14, 2019

Crohn Disease Trial in Ann Arbor (Low serine diet, High serine diet)

Recruiting
  • Crohn Disease
  • Low serine diet
  • High serine diet
  • Ann Arbor, Michigan
    University of Michigan
May 19, 2022

Amyotrophic Lateral Sclerosis (ALS) Trial in Lebanon (L-Serine)

Recruiting
  • Amyotrophic Lateral Sclerosis (ALS)
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Feb 22, 2022

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Recruiting
  • Metastatic Melanoma
  • +5 more
  • Aldesleukin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 10, 2020

Liposarcoma, Atypical Lipomatous Tumor Trial in Montpellier (Blood sampling)

Recruiting
  • Liposarcoma
  • Atypical Lipomatous Tumor
  • Blood sampling
  • Montpellier, France
    Institut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022